Albert Cortés

Hematologist at Hospital Clínic, Barcelona

[Albert Cortés @a_cortesbu]

Safety and efficacy of CD19 CAR-T therapy in patients with DLBCL and GI involvement. Happy to share these results with @app1279 and @MichaelDJain

[Ariel Perez @app1279]

Can LBCL patients with GI tract involvement achieve durable remissions? What is the risk of local complications? Check out our paper with @MarcoLDavila @MichaelDJain Outcomes of CD19 CAR T cell therapy in patients with gastrointestinal ... https://t.co/6vGtyIpBPb

[Aina Oliver-Caldes @ainitaoliver]

Feeling very happy and fulfilled with the support of my @hematoclinicbcn colleagues at #ASH23 Gràcies 🥰 #ARI0002h #ARI001

[Albert Cortés @a_cortesbu]

@cjimenezvicente Felicitats Carlos 😁

[Societat Catalana de Biologia @SCB_iec]

🏆@oriol_pich ha guanyat el #PremiSCB2023 a al #JoveInvestigador per la tesi “The role of mutational processes in the evolution of somatic tissues and malignancy” @UPFBarcelona @UPFBiomed

#NitBio2023 #PremisSCB2023

[Oriol Pich @oriol_pich]

Our latest from @SwantonLab out in @Nature, where we describe how air pollutants promote lung cancer 🥳 congrats to everybody involved, especially the superstars @WillHilliam @LimEmilia @DrClareWeeden 🎸 So grateful to have been a part of this project!!

[Hagop Kantarjian,MD @DrHKantarjian]

A new model to predict survival after low-intensity chemoRx in older #AML published by Dr. Koji Sasaki of @MDAndersonNews #Leukemia, @JournalCancer online
https://t.co/7r4jA6r7Za
#leusm

[Hematologia Hospital Clínic Barcelona @hematoclinicbcn]

👨‍🎓Enhorabuena al Dr.Valentin Ortiz-Maldonado @ValentinOrtizMD, por la fantástica disertación de su Tesis Doctoral titulada “Seguridad y eficacia de Varnicel en Sx linfoproliferativos CD19 positivos”.

👏 Felicidades por este gran logro 👏

@hospitalclinic
@immunoclinicbcn

[bbglab @bbglab]

We have been two great and intensive days at Montseny for our 2022 Retreat.
We bring home lots of new knowledge and fun, and specially a very nice and strong sense of belonging to a great group of people doing great science.

[Oriol Pich @oriol_pich]

We are delighted to share our review ‘The translational challenges of precision oncology’ in @Cancer_Cell, co-authored with @cbailey_58 under the guidance of @CharlesSwanton and our team 💪🏾 @tbkwatkins @ZaccaSimo @MariamJHanjani https://t.co/Hf37T28DrG 1/11

[Albert Cortés @a_cortesbu]

@AMartinezRocaMD @paraulogic Brunzit ;)

[Alexandra Martínez-Roca. MD. @AMartinezRocaMD]

👏👏3 charlas fantásticas de @ValentinOrtizMD sobre nuestro ARI-0001 en #leusm y #LLC👏👏

#Hemato2021
@hospitalclinic

[Hematología SantPau @hematosantpau]

Excelente revisión por @nilalbiol The road to chemotherapy-free treatment in #CLL Current Opinion in Oncology https://t.co/Zjt7HV7PLY

[Nil Albiol @nilalbiol]

Published in Cancer J. by @Wolters_Kluwer!!!
Autoimmune cytopenia (AIC) is a common feature in CLL (up to 10-15% of patients). In this review, Carol Moreno and I focus on the prognostic impact of AIC in CLL and their management, including novel therapies.
https://t.co/9IC9lryyxh

[Vincent Rajkumar @VincentRK]

Ten slides that summarize current diagnosis and treatment of multiple myeloma, smoldering myeloma, and MGUS. For clinical practice or the boards. #medtwitter

1. Diagnostic Criteria and Disease Definitions

[Albert Cortés @a_cortesbu]

@oriol_pich @nlbigas @abel_gonzalezp @fmuinos sheded some light on the genesis of therapy related AML by proving platinum based drugs can cause a direct and clonal damage to myeloid blasts. Happy to have been part of this with @hematosantpau . Thanks mate @oriol_pich 😘

[Oriol Pich @oriol_pich]

Chemotherapy, mutations, healthy cells, clonal expansions, hematopoiesis, leukemia...👀
These and much more in our paper “The evolution of hematopoietic cells under cancer therapy” out in @NatureComms from @bbglab & @hematosantpau.
So happy!!
https://t.co/8ZDkVJEexp
Tweetorial👇🏾

[Albert Cortés @a_cortesbu]

https://t.co/YDaToWaBod

[Albert Cortés @a_cortesbu]

Safety and efficacy of CD19 CAR-T therapy in patients with DLBCL and GI involvement. Happy to share these results with @app1279 and @MichaelDJain

[Ariel Perez @app1279]

Can LBCL patients with GI tract involvement achieve durable remissions? What is the risk of local complications? Check out our paper with @MarcoLDavila @MichaelDJain Outcomes of CD19 CAR T cell therapy in patients with gastrointestinal ... https://t.co/6vGtyIpBPb

[Albert Cortés @a_cortesbu]

@mcorrochanof @hematosantpau 😍😍 la mejor!!!

[Albert Cortés @a_cortesbu]

@ImLucia_GP 😍😍 el placer es mío!

[Irene García-Cadenas @Irenedenuevo]

Motivación contagiosa. ¡Habeis estado de 10! @hematosantpau #MIR #inmunoterapia